Axsome Therapeutics (AXSM) Total Debt Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -32.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.10% |
| Dec 31, 2025 | -29.30% |
| Sep 30, 2025 | -32.32% |
| Jun 30, 2025 | 0.63% |
| Mar 31, 2025 | 2.65% |
| Dec 31, 2024 | -2.04% |
| Sep 30, 2024 | 2.18% |
| Jun 30, 2024 | 1.75% |
| Mar 31, 2024 | 20.48% |
| Dec 31, 2023 | 84.18% |
| Sep 30, 2023 | 82.45% |
| Jun 30, 2023 | 84.25% |
| Mar 31, 2023 | 211.51% |
| Dec 31, 2022 | 104.03% |
| Sep 30, 2022 | 105.22% |
| Jun 30, 2022 | 103.36% |
| Mar 31, 2022 | 1.47% |
| Dec 31, 2021 | 1.59% |
| Sep 30, 2021 | 2.39% |
| Jun 30, 2021 | 140.90% |
| Mar 31, 2021 | 141.63% |
| Dec 31, 2020 | 142.40% |
| Sep 30, 2020 | 143.09% |
| Jun 30, 2020 | 3.64% |
| Mar 31, 2020 | 3.92% |
| Dec 31, 2019 | 188.46% |
| Sep 30, 2019 | 155.72% |
| Jun 30, 2019 | 131.15% |
| Mar 31, 2019 | 110.19% |
| Dec 31, 2018 | -30.42% |
| Sep 30, 2018 | -23.45% |
| Jun 30, 2018 | -15.06% |
| Mar 31, 2018 | -6.57% |
| Dec 31, 2017 | 1.98% |